Cancer Gene Therapy

Papers
(The H4-Index of Cancer Gene Therapy is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Key chemokines direct migration of immune cells in solid tumors237
Cancer-associated fibroblasts: overview, progress, challenges, and directions183
The KRAS-G12C inhibitor: activity and resistance89
Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study73
LOX-1 and cancer: an indissoluble liaison65
Nanomedicine-based cancer immunotherapy: recent trends and future perspectives53
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy49
CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model46
Protein post-translational modifications in the regulation of cancer hallmarks46
Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy45
The V-ATPases in cancer and cell death44
Roles of miRNA dysregulation in the pathogenesis of multiple myeloma42
Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma41
Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance41
Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model40
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential38
Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling path34
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy31
LncRNAs in breast cancer: a link to future approaches30
LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma30
Cytokine-enhanced cytolytic activity of exosomes from NK Cells30
Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma30
Elevating microRNA-1-3p shuttled by cancer-associated fibroblasts-derived extracellular vesicles suppresses breast cancer progression and metastasis by inhibiting GLIS129
Recent progress in exosome research: isolation, characterization and clinical applications28
Delivery technologies to engineer natural killer cells for cancer immunotherapy28
Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness28
LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway27
0.046715021133423